Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chikuma Hamada

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Journal of Biopharmaceutical Statistics|March 11, 2014
Bayesian model averaging continual reassessment method for bivariate binary efficacy and toxicity outcomes in phase I oncology trialsTakashi Asakawa, Akihiro Hirakawa, Chikuma Hamada
Neuroepidemiology|February 5, 2003
Projection of creutzfeldt-jakob disease frequency based on cadaveric dura transplantation in JapanChikuma Hamada, Tetsuji Sadaike, Masanori Fukushima
Methods of Information in Medicine|March 14, 2009
A note on estimating treatment effect for time-to-event data in a literature-based meta-analysisTadashi Hirooka, Chikuma Hamada, Isao Yoshimura
Statistical Applications in Genetics and Molecular Biology|October 24, 2012
A modified maximum contrast method for unequal sample sizes in pharmacogenomic studiesKengo Nagashima, Yasunori Sato, Chikuma Hamada
Computational and Mathematical Methods in Medicine|July 7, 2015
Enhancing the Lasso Approach for Developing a Survival Prediction Model Based on Gene Expression DataShuhei Kaneko, Akihiro Hirakawa, Chikuma Hamada
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|June 13, 2009
[Survey of statistical analysis in Journal of Pharmacological Sciences: typical inappropriate uses and countermeasures against them]Chikuma Hamada, Rio Akazawa, Tomoe Nishizawa
Journal of Biopharmaceutical Statistics|December 11, 2019
Performance of randomization-based causal methods with and without integrating external data sources for adjusting overall survival in case of extensive treatment switches in placebo-controlled randomized oncology phase 3 trialsShogo Nomura, Tomohiro Shinozaki, Chikuma Hamada
Statistics in Medicine|April 6, 2006
A method for therapeutic dose selection in a phase II clinical trial using contrast statisticsAkira Wakana, Isao Yoshimura, Chikuma Hamada
Biometrical Journal. Biometrische Zeitschrift|April 12, 2013
Partition testing in confirmatory adaptive designs with structured objectivesToshifumi Sugitani, Toshimitsu Hamasaki, Chikuma Hamada
Neuroepidemiology|October 2, 2004
Creutzfeldt-Jakob disease and cadaveric dura mater grafts in Japan: an updated analysis of incubation timeShigeyuki Matsui, Tetsuji Sadaike, Chikuma Hamada, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Journal of Biopharmaceutical Statistics|March 11, 2014
Bayesian model averaging continual reassessment method for bivariate binary efficacy and toxicity outcomes in phase I oncology trialsTakashi Asakawa, Akihiro Hirakawa, Chikuma Hamada
Neuroepidemiology|February 5, 2003
Projection of creutzfeldt-jakob disease frequency based on cadaveric dura transplantation in JapanChikuma Hamada, Tetsuji Sadaike, Masanori Fukushima
Methods of Information in Medicine|March 14, 2009
A note on estimating treatment effect for time-to-event data in a literature-based meta-analysisTadashi Hirooka, Chikuma Hamada, Isao Yoshimura
Statistical Applications in Genetics and Molecular Biology|October 24, 2012
A modified maximum contrast method for unequal sample sizes in pharmacogenomic studiesKengo Nagashima, Yasunori Sato, Chikuma Hamada
Computational and Mathematical Methods in Medicine|July 7, 2015
Enhancing the Lasso Approach for Developing a Survival Prediction Model Based on Gene Expression DataShuhei Kaneko, Akihiro Hirakawa, Chikuma Hamada
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|June 13, 2009
[Survey of statistical analysis in Journal of Pharmacological Sciences: typical inappropriate uses and countermeasures against them]Chikuma Hamada, Rio Akazawa, Tomoe Nishizawa
Journal of Biopharmaceutical Statistics|December 11, 2019
Performance of randomization-based causal methods with and without integrating external data sources for adjusting overall survival in case of extensive treatment switches in placebo-controlled randomized oncology phase 3 trialsShogo Nomura, Tomohiro Shinozaki, Chikuma Hamada
Statistics in Medicine|April 6, 2006
A method for therapeutic dose selection in a phase II clinical trial using contrast statisticsAkira Wakana, Isao Yoshimura, Chikuma Hamada
Biometrical Journal. Biometrische Zeitschrift|April 12, 2013
Partition testing in confirmatory adaptive designs with structured objectivesToshifumi Sugitani, Toshimitsu Hamasaki, Chikuma Hamada
Neuroepidemiology|October 2, 2004
Creutzfeldt-Jakob disease and cadaveric dura mater grafts in Japan: an updated analysis of incubation timeShigeyuki Matsui, Tetsuji Sadaike, Chikuma Hamada, et al.
Pageof 10